Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> COP27: World Bank, IRENA Pledge over $1 Billion to Solar Electrification of Health Facilities 09/11/2022 Megha Kaveri SHARM EL-SHEIKH, Egypt – The International Renewable Agency (IRENA), on Tuesday, said it would pump $1billion into a new effort that would electrify health facilities, along with food storage and agriculture, with solar power, while the World Bank said it also plans to triple its investments in solar electrification efforts to reach 100,000 health facilities […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Skin to Skin Contact between Mothers and Preterm, Underweight Babies Improve Chances of Survival, says WHO 15/11/2022 Megha Kaveri The World Health Organization (WHO) has strongly recommended that babies born before 37 weeks of gestation (preterm) or with low birth weight should be provided immediate skin to skin contact with a caregiver, which in turn increases their chances of survival. This recommendation by the global health agency is a significant change from the previous […] Continue reading -> WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> COP27: World Bank, IRENA Pledge over $1 Billion to Solar Electrification of Health Facilities 09/11/2022 Megha Kaveri SHARM EL-SHEIKH, Egypt – The International Renewable Agency (IRENA), on Tuesday, said it would pump $1billion into a new effort that would electrify health facilities, along with food storage and agriculture, with solar power, while the World Bank said it also plans to triple its investments in solar electrification efforts to reach 100,000 health facilities […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Biosimilar Guidelines Are a Tepid Attempt to Improve Access and Affordability 12/11/2022 KM Gopakumar & Chetali Rao Biotherapeutic products represent a new therapeutic revolution in disease treatment and are by far the fastest-growing segment of the pharmaceutical industry – yet the recent biosimilar guidelines issued by the World Health Organization (WHO) are myopic, inconsistent or vague about some well-established scientific issues Biosimilar products include recombinant proteins and hormones, monoclonal antibodies (mAbs), cytokines, […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> COP27: World Bank, IRENA Pledge over $1 Billion to Solar Electrification of Health Facilities 09/11/2022 Megha Kaveri SHARM EL-SHEIKH, Egypt – The International Renewable Agency (IRENA), on Tuesday, said it would pump $1billion into a new effort that would electrify health facilities, along with food storage and agriculture, with solar power, while the World Bank said it also plans to triple its investments in solar electrification efforts to reach 100,000 health facilities […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> COP27: World Bank, IRENA Pledge over $1 Billion to Solar Electrification of Health Facilities 09/11/2022 Megha Kaveri SHARM EL-SHEIKH, Egypt – The International Renewable Agency (IRENA), on Tuesday, said it would pump $1billion into a new effort that would electrify health facilities, along with food storage and agriculture, with solar power, while the World Bank said it also plans to triple its investments in solar electrification efforts to reach 100,000 health facilities […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COP27: World Bank, IRENA Pledge over $1 Billion to Solar Electrification of Health Facilities 09/11/2022 Megha Kaveri SHARM EL-SHEIKH, Egypt – The International Renewable Agency (IRENA), on Tuesday, said it would pump $1billion into a new effort that would electrify health facilities, along with food storage and agriculture, with solar power, while the World Bank said it also plans to triple its investments in solar electrification efforts to reach 100,000 health facilities […] Continue reading -> Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Uganda and WHO to Test Vaccine Candidates to Combat Country’s Ebola Outbreak 04/11/2022 Stefan Anderson On Friday, the Ebola taskforce of Kassanda district in Uganda delivered the remains of four people that succumbed to the the virus for burial to their home village of Kitongo. Three of the bodies belong to family members who died from exposure to the virus after they exhumed a loved one they had lost to […] Continue reading -> Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Undertakes to Change Vaccine Procurement to Support New African Manufacturers 03/11/2022 Kerry Cullinan Gavi, the global vaccine alliance, has undertaken to adapt its approach to procuring vaccines in order to support African vaccine manufacturing. In a plan released on Thursday, Gavi has committed to placing “a higher value on the benefits of diversification to supply security, with a focus on Africa”. The 10-point plan, developed in consultation with […] Continue reading -> Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Omicron Subvariants Race for Dominance 31/10/2022 Stefan Anderson The SARS-CoV2 virus just won’t give up. As the northern hemisphere heads into its third pandemic winter, experts say the continued evolution of Omicron’s sub-variants indicates a fresh wave is coming, but no one knows which variant will fuel it. Scientists have catalogued 390 Omicron lineages and 48 recombinants of the virus – which occur […] Continue reading -> Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Cough Medicine Deaths Highlight India’s Problem With Sub-standard Medicine 31/10/2022 Shuriah Niazi NEW DELHI – Govind Ram is still waiting to get justice for the death of his daughter in 2019 – who allegedly died from contaminated cough syrup. In December 2019, Ram’s two-year-old, Surabhi, had a fever and chest congestion. Ram, a labourer in the Udhampur district of India’s Jammu and Kashmir region, took his daughter […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> Posts navigation Older postsNewer posts